Cargando…

P1214: CTPS1 ACTS AS A PROGNOSTIC BIOMARKER AND THERAPEUTIC TARGET IN MANTLE CELL LYMPHOMA

Detalles Bibliográficos
Autores principales:	Ren, Yi-Min, Liang, Jinhua, Du, Kai-Xin, Wang, LI, Wang, Rong, LI, Jianyong, Xu, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431190/ http://dx.doi.org/10.1097/01.HS9.0000971752.24777.82

Ejemplares similares

Differential roles of CTP synthetases CTPS1 and CTPS2 in cell proliferation
por: Minet, Norbert, et al.
Publicado: (2023)

Interfilament interaction between IMPDH and CTPS cytoophidia
por: Chang, Chia‐Chun, et al.
Publicado: (2018)

P1113: PROGNOSTIC ROLE OF GENETIC ABNORMALITIES IN MANTLE CELL LYMPHOMA
por: Kleina, E., et al.
Publicado: (2022)

P864: CTPS1 IS A NOVEL THERAPEUTIC TARGET IN MYELOMA - SELECTIVE SMALL MOLECULE INHIBITION DELIVERS SINGLE AGENT ACTIVITY AND SYNERGISES WITH ATR INHIBITION
por: Pfeiffer, C., et al.
Publicado: (2022)

ASNS disruption shortens CTPS cytoophidia in Saccharomyces cerevisiae
por: Zhang, Shanshan, et al.
Publicado: (2021)

Fat body-specific reduction of CTPS alleviates HFD-induced obesity
por: Liu, Jingnan, et al.
Publicado: (2023)

Structural basis for isoform-specific inhibition of human CTPS1
por: Lynch, Eric M., et al.
Publicado: (2021)

1214. Clinical characteristics of patients with adrenal insufficiency presenting fever
por: Jang, wooyoung, et al.
Publicado: (2020)

P1308: SELECTIVE SMALL MOLECULE INHIBITION OF CTP SYNTHASE 1 (CTPS1) SUPPRESSES T CELL PROLIFERATION AND CYTOKINE RELEASE, HIGHLIGHTING A NOVEL THERAPEUTIC TARGET FOR GRAFT-VERSUS-HOST DISEASE
por: Beer, P., et al.
Publicado: (2022)

P1214: SUBCUTANEOUS EPCORITAMAB + R-CHOP FOR FIRST-LINE TREATMENT OF PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA: PHASE 1/2 UPDATE
por: Clausen, M. R., et al.
Publicado: (2022)

P1155: MORE PRECISE RISK STRATIFICATION FOR TP53 MUTANT DIFFUSE LARGE B CELL LYMPHOMA
por: Du, Kai-Xin, et al.
Publicado: (2023)

P1096: TREATMENT PATTERNS AND OUTCOMES IN RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA
por: Bock, A., et al.
Publicado: (2022)

Targeting cyclin D1 for mantle cell lymphoma
por: Chen, Jingtao
Publicado: (2015)

Combined Inactivation of CTPS1 and ATR Is Synthetically Lethal to MYC-Overexpressing Cancer Cells
por: Sun, Zhe, et al.
Publicado: (2022)

Seronegative Mediastinal Coccidioidomycosis as a Novel Presentation of CTPS1 Combined Immunodeficiency
por: Krase, Ifat Z, et al.
Publicado: (2022)

P1259: CHARACTERIZATION OF VENETOCLAX RESISTANCE IN CELL MODELS OF MANTLE CELL LYMPHOMA
por: Granau, A., et al.
Publicado: (2022)

Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents
por: Inamdar, Arati A., et al.
Publicado: (2016)

P1155: BREXUCABTAGENE AUTOLEUCEL FOR RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA IN ROUTINE PRACTICE: UPDATED REPORT FROM THE US LYMPHOMA CAR T CONSORTIUM
por: Wang, Y., et al.
Publicado: (2022)

P1145: PRELIMINARY RESULTS OF PENPULIMAB COMBINED WITH RMA(RITUXIMAB, METHOTREXATE, AND CYTARABINE) FOR NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)
por: Shen, Haorui, et al.
Publicado: (2023)

CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1
por: Lin, Yuxiang, et al.
Publicado: (2022)

Coupled structural transitions enable highly cooperative regulation of human CTPS2 filaments
por: Lynch, Eric M., et al.
Publicado: (2019)

Targeting glutaminase is therapeutically effective in ibrutinib-resistant mantle cell lymphoma
por: Li, Lingzhi, et al.
Publicado: (2022)

P1151: METABOLIC TUMOR VOLUME IMPROVES OUTCOME PREDICTION IN UNTREATED MANTLE CELL LYMPHOMA
por: Vergote, V. K., et al.
Publicado: (2022)

Integrative Prognostic Machine Learning Models in Mantle Cell Lymphoma
por: Hill, Holly A., et al.
Publicado: (2023)

P1279: INHIBITION OF PROTEIN KINASE CK2 AND BCL-2: A NOVEL THERAPEUTIC STRATEGY TO ANTAGONIZE MANTLE CELL LYMPHOMA CELL GROWTH
por: Manni, S., et al.
Publicado: (2022)

Rac1 is a novel therapeutic target in mantle cell lymphoma
por: Tian, Tian, et al.
Publicado: (2018)

15-deoxy-delta(12,14)-prostaglandin J(2 )induces apoptosis in human articular chondrocytes
por: Masuko-Hongo, K, et al.
Publicado: (2003)

1214. Household Transmission of Febrile Illness Measured by Smartphone-Connected Thermometers, United States, 2016-2021
por: Bloch, Danielle, et al.
Publicado: (2021)

P1131: POST HOC ANALYSIS OF PATIENTS WITH HIGHLY PROLIFERATIVE VARIANTS OF MANTLE CELL LYMPHOMA TREATED WITH ACALABRUTINIB
por: Le Gouill, S., et al.
Publicado: (2022)

P1133: CHIDAMIDE PLUS PREDNISONE, CYCLOPHOSPHAMIDE, AND THALIDOMIDE (CPCT) FOR RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA: A MULTICENTER PHASE II TRIAL
por: Liang, Jinhua, et al.
Publicado: (2023)

P1216: CD30 PROTECTS EBV-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA CELLS AGAINST MITOCHONDRIAL DYSFUNCTION THROUGH INCREASING BNIP3 EXPRESSION
por: Wang, Wei-Ting, et al.
Publicado: (2023)

P1246: DIFFERENTIAL ROLE OF MICROENVIRONMENT AND STROMAL-CELL INDUCED VENETOCLAX RESISTANCE IN MANTLE CELL LYMPHOMA
por: Andersen, P., et al.
Publicado: (2022)

Bortezomib in mantle cell lymphoma: comparative therapeutic outcomes
por: Vallumsetla, Nishanth, et al.
Publicado: (2015)

Impact of Coronavirus (COVID-19) Pandemic on Maintenance Therapy for Follicular Lymphoma (FL) and Mantle Cell Lymphoma (MCL)
por: Serna, Angel, et al.
Publicado: (2022)

The clinical features, therapeutic responses, and prognosis of the patients with mantle cell lymphoma
por: Ying, Zhi-Tao, et al.
Publicado: (2012)

CD10-positive mantle cell lymphoma: clinicopathologic and prognostic study of 30 cases
por: Xu, Jie, et al.
Publicado: (2017)

P1295: DECIPHERING THE ROLE OF MSI2 AS A REGULATOR OF MANTLE CELL LYMPHOMA STEM-LIKE PROPERTIES
por: Sureda-Gómez, M., et al.
Publicado: (2022)

Smoldering mantle cell lymphoma
por: Ye, Haige, et al.
Publicado: (2017)

Therapeutic Activity of Lenalidomide in Mantle Cell Lymphoma and Indolent Non-Hodgkin's Lymphomas
por: Gunnellini, Marco, et al.
Publicado: (2012)

P1250: EU-SOX11CCND1: A NOVEL IMMUNOCOMPETENT MURINE MODEL OF MANTLE CELL LYMPHOMA
por: Brown, F., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nrn6lfm38eh5elec0tmtegpllq